Acambis Withdraws Arilvax Yellow Fever Vaccine BLA Pending Chiron Plant Upgrade
This article was originally published in The Pink Sheet Daily
Executive Summary
The manufacturing facility is expected to be ready for FDA's pre-approval inspection by mid-2005, at which time Acambis will resubmit the application.